Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
RARE: Ultragenyx Pharmaceutical Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
RARE
The Story
RARE
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+29.0% / yr
Operating margin
-83.9%
ROIC
-53.9%
Financially safe
Stretched
Debt / equity
-5.08×
Interest coverage
-8.2×
Current ratio
2.02×
Ultragenyx Pharmaceutical Inc.
RARE
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Ultragenyx Pharmaceutical Inc.
RARE
NASDAQ
·
USD
·
Closed
$24.91
−4.34%
$24.91
−$1.13 (4.34%)
52W Range
31th
pctl
Volume
0.70×
avg
Mkt Cap
2.45B
USD
P/E
-4.1
TTM
Div Yield
–
ann
52W Range
31th
pctl
Volume
0.70×
avg
Market Cap
2.45B
USD
P/E Ratio
-4.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings